Mizuho raises Aflac stock price target to $112 on higher estimates

Mizuho raised its price target for Aflac (AFL) to $112, citing higher estimates, while maintaining an Underperform rating. AFL's Q3 2026 EPS matched estimates at $1.80. The company's revenue missed expectations at $3.27B vs. $4.11B forecast. Mizuho increased its fiscal 2026 EPS estimate to $7.70, reflecting a 9% increase. AFL's stock trades at $124.06, above the new target.

Original reporting
Published Nov 9, 2026, 11:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 12:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AFL
Bearish
high confidence
Mentioned
$AFL
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AFLBearishLow
01

Why it matters

The target raise reflects higher earnings estimates but a narrower discount, which may not be enough to move the stock higher.

02

Market read

Aflac's shares are already above the new target, so the news may prompt short-term traders to take profits.

03

What to watch

Aflac's strong dividend history and capital allocation could offset the lower target for long-term holders.

Relevance 7/10Novelty 6/10Timing: today

Background

Mizuho's price target adjustment follows Aflac's Q3 earnings beat on EPS but a revenue miss.

Company-level read

Ticker impact

$AFLBearishHigh confidence
Context

Mizuho raised its price target on Aflac to $112 from $107 and kept an Underperform rating.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Analyst target cuts often lead to short-term sell pressure, especially when the stock trades above the target.

Market effects

Minimal; the change affects only Aflac within the insurance sector.

U.S. equity market impact is limited to Aflac's share price.

Low; no broader macro or global implications.

Counterpoint

Some investors may view the target raise as a sign of confidence despite the stock trading above it.

Key entities

  • Mizuho

    Equity research firm that issued the new price target.

  • Aflac

    Insurance company whose stock is the subject.

Related articles

$AFLMedAI 8/10

Aflac (AFL) Net Income Fell 81.5% In Q3 2026

Aflac (AFL) reported an 81.5% drop in Q3 2026 net income due to investment losses, though adjusted earnings were more stable. The company raised its dividend for the 44th consecutive year and announced a leadership transition. Aflac's market value is approximately $62.4 billion, focusing on supplemental health and life policies.

$AFLMedAI 8/10

Aflac Q3 Earnings Call Highlights

Aflac reported Q3 earnings, noting increased sales of Tsumitas, which now represents 20% of Japan sales. Japan's net earned premiums declined 2%, but the company expects a 2026 pretax profit margin of 35-38%. Aflac Japan ceded 500 billion yen of cancer insurance reserves, releasing $1 billion in capital. U.S. sales rose 3.5%, with a pretax profit margin of 27.7%. The company repurchased $804 million in stock and announced leadership changes for 2027.

$AFLHighAI 8/10

Aflac Inc (AFL) (Q3 2026) Earnings Call Highlights: Actuarial Gains and Reinsurance

Aflac Inc (AFL) reported Q3 2026 earnings, raising Aflac Japan's pre-tax profit margin outlook to 35%-38%. Aflac US sales grew 3.5% YoY. The company returned $1.1B to shareholders and completed a reinsurance transaction releasing $1B in capital. Challenges included a 4% YoY sales decline in Aflac Japan and increased cybersecurity expenses. Adjusted EPS was $2.43, with actuarial gains and cyber costs impacting results.

$AFLHighAI 8/10

Aflac Inc (AFL) Q3 2026 Earnings Call Transcript

Aflac Inc (AFL) reported Q3 2026 net earnings of $0.61 per share and adjusted earnings of $2.43. Sales in Japan declined 4% but rose 3% year-to-date. US sales increased 3.5%. The company announced leadership promotions effective 2027. Aflac returned $1.1B to shareholders in the quarter, maintaining 44 years of dividend increases. Adjusted earnings per share decreased 1.2% year-over-year, with a 17.8% adjusted ROE.

$AFLHighAI 8/10

Aflac (NYSE:AFL) misses Q3 2026 revenue estimates

Aflac (AFL) reported Q3 2026 revenue of $3.27B, missing estimates by 22.4% and declining 25.8% YoY. Adjusted EPS of $2.43 beat estimates by 35.2%, and book value per share grew 8.3% YoY to $59.08. The company's revenue has declined 6.2% annually over five years, while book value grew 3.1% annually over the same period.